Variation in KSHV prevalence between geographically proximate locations in Uganda.
KSHV
Seroprevalence
Uganda
Various populations
Journal
Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
05
2020
accepted:
15
07
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
28
7
2020
Statut:
epublish
Résumé
Kaposi's sarcoma-associated herpesvirus (KSHV) transmission within endemic areas may vary. KSHV seroprevalence has been studied by different groups of researchers using different methods, making it difficult to make direct comparisons. Here we show results on KSHV seroprevalence using the same laboratory method from four different but geographically proximate populations in Uganda. Blood samples from the urban Entebbe Mother and Baby Study (EMaBS), the rural General Population Cohort (GPC), the fishing community Lake Victoria Island Intervention Study on Worms and Allergy related Diseases (LaVIISWA) and the high-risk sexual behaviour Good Health for Women Project (GHWP), were tested for IgG antibody levels to K8.1 and ORF73 recombinant proteins using ELISA. All adult participants of the EMaBS study and the GHWP were women, while the GPC (54% female) and LaVIISWA (52% female) studies had both males and females. EMaBS children were all 5 years of age while their mothers were 14 to 47 years of age. GHWP women were 15 to 45 years old, LaVIISWA participants were 1 to 72 years old while GPC participants were 1 to 103 years old. KSHV seropositivity varied in the different populations. In children aged 5 years, EMaBS had the lowest prevalence of 15% followed by GPC at 35% and LaVIISWA at 54%. In adult women, seropositivity varied from 69% (EMaBS) to 80% (LaVIISWA) to 87% (GPC) to 90% (GHWP). The reasons for the variation in prevalence are unclear but may reflect differences in the prevalence of cofactors between these four geographically proximate populations.
Identifiants
pubmed: 32714434
doi: 10.1186/s13027-020-00313-8
pii: 313
pmc: PMC7376633
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49Subventions
Organisme : Medical Research Council
ID : MC_UU_00027/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsNon declared.
Références
AIDS. 2000 Mar 10;14(4):427-34
pubmed: 10770546
BMC Infect Dis. 2005 Dec 21;5:115
pubmed: 16371154
J Med Virol. 2001 Sep;65(1):123-32
pubmed: 11505454
Sex Transm Dis. 2011 Apr;38(4):316-23
pubmed: 23330152
Pediatr Infect Dis J. 2018 Aug;37(8):e225-e228
pubmed: 29369149
Lancet. 2011 Jan 1;377(9759):52-62
pubmed: 21176950
Clin Infect Dis. 2019 Sep 26;:
pubmed: 31555829
BMC Psychiatry. 2011 Jun 08;11:97
pubmed: 21651809
BMC Public Health. 2020 Mar 18;20(1):353
pubmed: 32183759
Trop Med Int Health. 2015 Feb;20(2):E1-10
pubmed: 25354929
J Oral Microbiol. 2017 Oct 15;9(1):1384287
pubmed: 29081916
Sex Transm Infect. 2016 Sep;92(6):447-54
pubmed: 26933046
Allergy. 2016 Aug;71(8):1156-69
pubmed: 26918891
Infect Agent Cancer. 2011 Sep 30;6(1):15
pubmed: 21962023
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):228-33
pubmed: 23403859
BMC Pregnancy Childbirth. 2015 Oct 29;15:279
pubmed: 26515763
J Infect Dis. 2018 Jan 4;217(2):263-269
pubmed: 29099933
Int J Epidemiol. 2013 Feb;42(1):129-41
pubmed: 23364209
J Infect Dis. 2018 Aug 24;218(7):1061-1065
pubmed: 29741631
Clin Infect Dis. 2019 May 2;68(10):1665-1674
pubmed: 30202872
Trials. 2015 Apr 23;16:187
pubmed: 25902705
Nat Rev Dis Primers. 2019 Jan 31;5(1):9
pubmed: 30705286
Int J Cancer. 2007 Jan 15;120(2):321-8
pubmed: 17066452
Parasitology. 2011 Oct;138(12):1499-507
pubmed: 21810307
Trop Med Int Health. 2015 May;20(5):665-672
pubmed: 25611008
Int J Cancer. 2015 Jun 15;136(12):2822-30
pubmed: 25395177
AIDS. 2008 Aug 20;22(13):1641-9
pubmed: 18670225
J Immunol Methods. 2010 Apr 30;356(1-2):39-46
pubmed: 20211626
Trop Med Int Health. 2015 Apr;20(4):527-36
pubmed: 25496206
AIDS. 2016 Jan 28;30(3):487-93
pubmed: 26765939
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Epidemiol. 2013 Dec;42(6):1740-53
pubmed: 24191304
Int J Epidemiol. 1996 Oct;25(5):1077-82
pubmed: 8921497
AIDS Care. 2013;25(6):767-74
pubmed: 23216336
PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007776
pubmed: 31618208